Overview


Amiodarone hydrochloride is an antiarrhythmic drug that treats heart rhythm disorders indicated to initiate treatment and prevent frequently recurring ventricular fibrillation and hemodynamically irregular ventricular tachycardia in patient’s refractory to further therapy or patients intolerant of other agents used for these conditions. It is used to reform a regular heartbeat and maintain a steady heartbeat. 

Amiodarone hydrochloride affects the electrical movement in the heart, helping to stabilize and control the heart rhythm. It can slow the heart rate and control irregular heartbeats, reducing the risk of potentially life-threatening arrhythmias. This drug is generally prescribed when the antiarrhythmic other medicines are ineffective or unsuitable. It is available in tablet form, as well as in injectable form for hospital use. The oral tablets are usually taken by mouth, often with food, and the dosage is decided by the individual's state and response to treatment.

Common side effects of amiodarone hydrochloride include nausea, vomiting, constipation, loss of appetite, shaking, or tiredness. If any of these effects last or worsen, inform the doctor immediately. 

FutureWise Market Research has published a report that provides an insightful amiodarone hydrochloride market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, amiodarone hydrochloride market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.
  • Piramal Pharma Limited
  • Olon
  • Glenmark Pharma
  • CTX Lifesciences
  • PMC Isochem
  • Zhejiang Sanmne Hengka
  • United Pharma Insutri
  • Cambrex Ltd
  • Unichem laboratories Limited
  • Arevipharma
  • Globe Quimica Ltda
  • Sanofi
  • Shanghai Pharmaceutical Group Co.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Developments in Amiodarone Hydrochloride Market:

  •  In 2021- A pharmaceutical company, Piramal Pharma Limited, took over Hemmo Pharmaceuticals Pvt Ltd., a leading Indian manufacturer of Peptide APIs, to enhance its product portfolio.

Growing prevalence of the senior population with age-related cardiac conditions, arrhythmias, and high risk of sudden deaths due to life-threatening ventricular arrhythmias is expected to boost the growth of the amiodarone hydrochloride market. These condition requires pharmacological treatments, and amiodarone hydrochloride is generally prescribed for addressing these arrhythmias effectively. In addition, rising awareness of cardiovascular disorders, regular check-ups, and proactive screening programs have led to the early detection of arrhythmias. Furthermore, the severe potential side effects associated with amiodarone hydrochlorides, such as pulmonary toxicity, thyroid dysfunction, and liver toxicity, pose significant safety concerns and may obstruct the market's growth. These side effects require regular monitoring and medical interventions, which can add to the treatment's overall expenditure and complexity. The increasing incidence of personalized medicines is increasing popularity in cardiovascular care. The opportunity to develop customized treatment approaches using amiodarone hydrochloride, considering individual patient characteristics, genetic predisposition, and comorbidities, healthcare experts can optimize the usage of Amiodarone Hydrochloride to gain better treatment results and improved efficacy.

By Product

  • Injections
  • Tablets
  • Capsules

By Purity Level

  • Purity >98%
  • Purity<98%

By Distribution Channel

  • Retail Pharmacies
  • Online Drug Stores
  • Hospital Pharmacies
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. Owing to the increasing demand for applications in the treatment options of cardiac arrhythmias, amiodarone hydrochloride expects to drive the market. The market offers pharmaceuticals and biotechnology companies opportunities to develop formulations and expand their product portfolios.
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Amiodarone Hydrochloride Market By Product, By Purity Level, By Distribution Channel and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Amiodarone Hydrochloride Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Amiodarone Hydrochloride Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Amiodarone Hydrochloride Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Amiodarone Hydrochloride Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Injections
        2. Tablets
        3. Capsules

  • 8.   Amiodarone Hydrochloride Market, By Purity Level Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Purity >98%
        2. Purity<98%

  • 9.   Amiodarone Hydrochloride Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Retail Pharmacies
        2. Online Drug Stores
        3. Hospital Pharmacies
        4. Others

  • 10.   North America Amiodarone Hydrochloride Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Amiodarone Hydrochloride Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Amiodarone Hydrochloride Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Amiodarone Hydrochloride Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Piramal Pharma Limited
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Olon
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Glenmark Pharma
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. CTX Lifesciences
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. PMC Isochem
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Zhejiang Sanmne Hengka
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. United Pharma Insutri
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Cambrex Ltd
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Unichem laboratories Limited
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
         10. Arevipharma
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Globe Quimica Ltda
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
         12. Sanofi
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
         13. Shanghai Pharmaceutical Group Co.
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11